Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Therapeutic effect of the potent integrin antagonist THR-687 in the cynomolgus laser-induced choroidal neovascularization model confirms its potential as novel treatment for sight-threatening retinal pathologies

Hu TT, Van Hove I, Vanhove M, Porcu M, Jonckx B, Barbeaux P, Feyen JHM, Vermassen E. Therapeutic effect of the potent integrin antagonist THR-687 in the cynomolgus laser-induced choroidal neovascularization model confirms its potential as novel treatment for sight-threatening retinal pathologies. 2018

Publication date: 
August, 2018
Attachment: 
PDF icon Abstract Euretina 2018_THR-687_THU_final.pdf
PDF icon Euretina 2018_THR-687_presentation.pdf